New patent expiration for Novartis drug TASIGNA

Annual Drug Patent Expirations for TASIGNA Tasigna is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents protecting…

The post New patent expiration for Novartis drug TASIGNA appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog